BRITISH MEDICAL ASSOCIATION

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Consolidated group

Auditor

Grant Thornton UK LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The BMA has undertaken an assessment of going concern and considered the level of disclosure relating to these issues within the financial statements. The directors have completed a detailed cashflow analysis to May 2026 together with business plan to 2028, including performing reverse stress testing which looked at a number of different scenarios such as a significant loss of members. Scenarios were created on a scale ranging from best to worst; worst being membership numbers returning to pre-industrial action levels in 2022 with 2% subscription rate increases and organisational costs remaining at the current level. The organisation performs regular financial reporting and forecasting which would allow any corrective action to be taken swiftly. Following this review and given the cash and investment portfolio controlled by the BMA Group, the directors have concluded that the BMA and BMA Group have sufficient resources to meet its ongoing liabilities for twelve months from the date that these financial statements have been signed, that there are no material uncertainties and as a result the accounts have been prepared on a going concern basis.”

Group structure

1. BRITISH MEDICAL ASSOCIATION · parent
   1. BMJ Publishing Group Limited 100% · London
   2. BMA Investments Limited 100% · London
   3. Medelect Limited 100% · London
   4. BMJ Publishing Inc. 100% · USA
   5. BMJ Group India Private Limited 100% · India
   6. BMJ (Beijing) Medical Science and Technology Co Limited 100% · China

Significant events

• “The BMA is carefully monitoring the impact of industrial and collective action on the finances of the BMA Group. Contingency plans are in place to fund any long-term industrial action from reserves. Reviews and reforecasts have not identified events or conditions that prevent the business from being able to meet obligations as they fall due. With strong cash reserves at Group level, possible adverse impact to working capital can be safely and effectively managed.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

13

last 12 months

Capital events

0

last 24 months

Officers appointed

3

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  +2%

  £153,672,000 → £156,773,000

• Cash

  +12.7%

  £50,501,000 → £56,925,000

• Net assets

  +7.7%

  £214,142,000 → £230,684,000

• Employees

  +2.8%

  1,041 → 1,070

• Operating profit

  +305.6%

  £2,216,000 → £8,988,000

• Profit before tax

  +39.1%

  £14,407,000 → £20,038,000

• Wages

  +2.8%

  £59,850,000 → £61,555,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers